Financial Performance - Operating revenue for Q1 2024 reached ¥849,455,030.91, a 11.85% increase from ¥759,370,808.58 in Q1 2023[1] - Operating profit for Q1 2024 was ¥26,203,466.19, a decrease of 5.88% compared to ¥27,847,772.98 in Q1 2023[1] - Net profit for Q1 2024 was ¥22,328,301.91, down 6.91% from ¥23,983,225.71 in Q1 2023[1] - Total revenue for Q1 2024 reached ¥1,606,131,612.95, an increase of 14.6% compared to ¥1,401,154,174.46 in Q1 2023[41] - Net profit attributable to shareholders for the first quarter of 2024 was CNY 40,938,738.76, a slight increase of 2.41% compared to CNY 39,974,785.82 in the previous year[12] - The total profit amounted to 48,137,146.72, compared to 47,475,945.32 in the previous period, indicating a rise of about 1.4%[42] - Basic and diluted earnings per share were both 0.14, up from 0.11 in the prior period, reflecting a growth of approximately 27.3%[43] Cash Flow - Cash flow from operating activities showed a net outflow of ¥86,319,787.11, compared to a net outflow of ¥15,460,049.18 in Q1 2023[3] - Cash inflow from operating activities totaled ¥1,497,823,347.36, an increase from ¥1,342,525,313.09 in Q1 2023[2] - Cash outflow from operating activities was ¥1,584,143,134.47, compared to ¥1,357,985,362.27 in Q1 2023[2] - The net cash flow from operating activities for the first quarter of 2024 was -CNY 86,319,787.11, a significant decline of 458.34% from -CNY 15,460,049.18 in the same period last year[12] - Net cash flow from operating activities decreased by 458.34% year-on-year, mainly due to increases in accounts receivable and inventory[14] - Net cash flow from investing activities increased by 800.17% year-on-year, primarily due to the purchase and maturity of financial products using temporarily idle funds[14] - Net cash flow from financing activities decreased by 100.18% year-on-year, mainly due to a lack of funds raised from stock issuance compared to the previous year[15] Assets and Liabilities - Total assets as of March 31, 2024, reached CNY 2,402,812,851.94, an increase of 3.81% compared to CNY 2,314,620,499.29 at the end of 2023[12] - The company's total liabilities to assets ratio (consolidated) increased to 38.60% from 37.79% year-over-year[12] - Current liabilities rose to ¥858,651,232.33, up from ¥802,974,463.26, indicating a 6.9% increase[37] - Non-current liabilities decreased slightly to ¥68,773,837.77 from ¥71,710,525.96, showing a reduction of 4.0%[37] - The ending cash and cash equivalents balance for Q1 2024 was ¥276,158,481.15, down from ¥541,248,317.18 in Q1 2023[3] Research and Development - The company reported a decrease in research and development expenses to ¥3,214,655.11 from ¥4,159,969.16 in Q1 2023, reflecting a 22.67% reduction[1] - The company reported a decrease in research and development expenses to ¥8,670,557.17 from ¥11,693,864.71, a reduction of 26.0%[41] Accounts Receivable and Inventory - Accounts receivable increased by 48.13% to CNY 269,173,187.72, primarily due to increased export business settled via credit certificates[12] - Accounts receivable increased significantly from 181,712,687.97 to 269,173,187.72, representing a growth of approximately 48%[35] - Inventory rose from 271,915,968.02 to 333,888,417.80, marking an increase of around 22.8%[35] - Inventory levels rose to ¥189,046,197.42, up from ¥145,940,718.86, indicating a 29.0% increase[38] Financial Expenses and Income - Financial expenses decreased by 241.86% to -CNY 4,362,631.85, attributed to increased exchange gains and interest income compared to the previous year[13] - The income tax expense was 7,198,407.96, a slight decrease from 7,501,159.50, indicating a reduction of about 4.0%[42] Shareholder Information - The top ten shareholders collectively hold 65.81% of the shares, with no inter-relationships among them[26] - The total number of ordinary shares at the end of the period was 291,132,748, with a decrease in unrestricted shares by 2,501,015[15] Other Information - The company has ongoing litigation involving an amount of 171,954.03, which has been carried over from 2023[30] - The total restricted assets amounted to 314,386,292.72, accounting for 13.08% of total assets, due to bank loan guarantees and other financial arrangements[32] - The company has no significant related party transactions or external guarantees during the reporting period[29] - There were no new acquisitions or mergers reported in the current quarter[29] - The company has fulfilled all disclosed commitments without any overdue obligations[30] - The company has not reported any significant changes in its product development or market expansion strategies during this period[42] - There were no reported gains or losses from asset disposals, indicating stable asset management practices[42]
一诺威(834261) - 2024 Q1 - 季度财报